APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.

Gastro-Intestinal System

Abnormal LFT Guidelines NENC Hepatology Network V2.2 January 2023
Bariatric GP guidance – amendment January 2023
Constipation guideline January 2023
Prescribing Trans Anal Irrigation – guidelines for prescribing 2019 v2.0

Cardiovascular System
Amiodarone SCG v1.1Amiodarone-SCG-v1.2
Angina Guideline January 2023
Atrial fibrillation – AHSN NENC
Dronedarone SCG January 2023
Northern England Evaluation and Lipid Intensification NEELI Clinical Guidelines (replaces FATS7)
Top Tips and Recommendations for Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in HFrEF; NTAG June 2022 
NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF; NTAG June 2022

Respiratory System
COPD Management Guidelines v2.2 Jan 2023
Asthma in children – Full Guideline January 2023
Asthma in children – Summary Guideline January 2023

Central Nervous system
Agomelatine – Primary Care Information Sheet v1.0
Dementia medicines leaflet January 2023
Adult ADHD Shared Care (extended March 2024)
Childrens-ADHD-Shared-care-June-2021 v1.2
Antipsychotic Leaflet update – August 2022
Dexamfetamine-for-Narcolepsy-SCG (extended to Feb 2024)
APC position statement non-palliative care use of opiates
Sativex-SCG-amended-Feb-2022 v1.0
Apomorphine shared care agreement V1.0Apomorphine-shared-care-agreement-V1.1

Regional Headache Guideline March 2022
Ketamine-in-Palliative-Care-pain-2020-v1.0 FILLABLE
Lithium-shared-care-NoTGNC-June-2022 v1.0
Methylphenidate-secondary-to-brain-injury-Sept-21 v1.0
Melatonin for the management of Sleep Wake Disorders in Children and Young People -Shared-Care amended January 2023
Melatonin Deprescribing Guideline March 2022
Vigabatrin SCG January 2023

Infections and antibiotics
NICE/PHE antimicrobial guidance: summary
Nebulised – Gentamicin Information-for-Primary-Care v2.0

Endocrine System
Denosumab information sheet – Dec 2021
Thyroid Gudelines (TRAMP2) June 2018
Osteoporosis (ext June 2022)
Gender Dyphoria Hormone Guidance August 22 V2
Menopause guidance January 2023
Topical testosterone for management of Low libido in menopausal women – January 2023

NICE Diabetes Guidance visual-summary-March 2022
Top Tips and Recommendations for use of Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in people with Type 2 Diabetes (T2DM) For Glycaemic Control: NTAG June 2022  

Genito-Urinary System
Erectile Dysfunction Guidelines for the investigation and management of men with ED Updated August 2022
Non Surgical Management of Overactive Bladder (OAB) Pathway February 2021
Urology Guidelines – March 22
Catheter Formulary and Guidance Sept 2021
Catheter info sheet v1.0
Urinary Continence Enablement Products and Devices Formulary 2021

Renal Disease
Top Tips and Recommendations for Dapagliflozin [FORXIGA] in Chronic Kidney Disease (CKD) ; NTAG June 2022
Renal Patients – Symptom Management v1.0

Malignant Disease and Immunosuppression
NoT G Monitoring of IMDs Updated Sept 2022
Lanreotide and Octreotide July 2019 v2.0
Tocilizumab monitoring SCG January 2023
NECN Palliative and End of life Symptom Control Guidelines 2021 (Fifth edition)

Immunosuppression following adult renal transplant

Nutrition and Blood
Erythropoietin-for-CKD-SCG – January 2023
Cows-milk-allergy-and-lactose-intolerance-guidance-January-2021 V3
Vitamin D Quick reference guide v3.0
Gluten free guidelines Updated Nov 2022
Oral Nutritional Support guidance and formulary FINAL v1.0 Jan 2021
Preterm Infant feeding prescribing guideline 2021-final
Faltering Growth February 2021 final

Musculoskeletal and Joint Diseases

Ear, Eyes, Nose and Throat
Newcastle upon Tyne ENT GP Referral Guidelines
Ophthalmology Referral Guidelines January 2023


Other Guidance
Prescribing intervals January 2023
Seven-day-Rx-and-MCAs v2.4
Stoma-Prescribing-Guidelines Sept 2020
Swallowing-difficulties v2.0
Third party ordering January 2023